Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 14Lymphoid 10Tumor-Agnostic 8Thoracic 8Other hematologic neoplasm 8Breast 8Gastrointestinal 6Gynecologic 4Dermatologic 3Head & Neck 2Genitourinary 2Sarcoma 1Plasma cell 1Other neoplasm 1Myeloid 1Classical hematology 1

Conditions

Neutropenia 1Mycoses 1Hematologic Neoplasms 1Febrile Neutropenia 1

Interventions

Epoetin Alfa 38Darbepoetin alfa 30epoetin beta 10Rivaroxaban 9olaparib 5eltrombopag 5apixaban 5Heparin, Low-Molecular-Weight 5pegylated granulocyte colony-stimulating factor 4pegfilgrastim 4emicizumab 4Gemcitabine 4Filgrastim 4Dalteparin 4Cyclophosphamide 4AP 1903 reagent 4romiplostim 3peginesatide 3luspatercept 3hetrombopag 3hematide 3Vancomycin 3ON 01910 3Enoxaparin 3Azacitidine 3ACE-011 3venetoclax 2telapristone acetate 2roxadustat 2iron isomaltoside 1000 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Itraconazole × Classical hematology × Clear all
NCT01706562 2013-02-20

A Study of Empirical Antifungal Therapy With Itraconazole

Janssen Korea, Ltd., Korea

Completed
138 enrolled
Classical hematologyOther hematologic neoplasm

Mycoses, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡